Sep 15
Current report
8-K
Events of Sep 9
Other events
Substantial doubt about the company's ability to continue as a going concern.
“management has determined that its history of losses and insufficient liquidity raise substantial doubt about the ability to continue as a going concern.”View the 10-Q filed Jul 16, 2025
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Useful current figures from the complete screener profile.
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Illustrative technical + ownership context — a signal mix, not investment advice.
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
KACLF
this stock
Kairous Acquisition Corp. Ltd
|
$66,463 | -83.8% | — | — | 0.0% |
|
VYLR
Vylor Inc.
|
$48.09B | — | — | — | 2.1% |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | — | — | — | — |
|
DMII
Drugs Made In America Acquisition II Corp.
|
$652.61M | +3.5% | — | — | 0.0% |
|
EVAC
EQV Ventures Acquisition Corp. II
|
$606.10M | +3.4% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| KACLF | -86.0% | -99.8% | -99.8% | -83.9% | -83.9% |
| SPY | -2.2% | -7.6% | -5.3% | -7.6% | -7.0% |
| vs SPY | -83.8% | -92.3% | -94.6% | -76.3% | -76.8% |